UPDATED Sep 29, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MDMA | CA$0.12 | 4.5% | 53.3% | CA$13.4m | n/a | PS29.2x | n/a | n/a | ||
NSRX | US$7.55 | -5.6% | n/a | US$72.5m | n/a | PE-44.1x | n/a | n/a | ||
HEPA | US$0.051 | -7.8% | -99.8% | US$639.1k | n/a | PB0.3x | n/a | n/a | ||
6891 | NT$34.15 | 9.1% | 23.7% | NT$6.8b | n/a | PS1319.6x | n/a | n/a | ||
4131 | NT$32.50 | 1.2% | 5.7% | NT$1.3b | n/a | PS8.5x | n/a | n/a | ||
4102 | NT$21.00 | 0.7% | -46.7% | NT$889.8m | n/a | PS1.7x | n/a | 5.5% | ||
6645 | NT$23.60 | -1.3% | -19.7% | NT$1.4b | n/a | PS2.8x | n/a | 0% | ||
4142 | NT$18.40 | 0.3% | -32.7% | NT$7.8b | n/a | PS4.8x | n/a | 0% | ||
4746 | NT$64.30 | -1.2% | -35.1% | NT$7.7b | NT$109.00 | PS1.6x | n/a | 4.7% | ||
4186 | NT$14.15 | 1.4% | -12.9% | NT$1.3b | n/a | PE54.4x | n/a | n/a | ||
507747 | ₹1,154.55 | -2.7% | -30.3% | ₹16.3b | n/a | PE25.9x | n/a | 0.9% | ||
1734 | NT$30.60 | 0.2% | -1.7% | NT$5.8b | n/a | PE18.8x | n/a | 3.1% | ||
7561 | NT$24.80 | -2.0% | 6.9% | NT$733.7m | n/a | PE24.1x | n/a | 0% | ||
6999 | NT$39.95 | -1.2% | 16.3% | NT$879.5m | n/a | n/a | n/a | 1.5% | ||
4120 | NT$49.75 | -2.5% | -4.3% | NT$4.3b | n/a | PB0.7x | n/a | 2.0% | ||
4172 | NT$20.05 | -4.3% | 5.2% | NT$2.2b | n/a | PS38.7x | n/a | n/a | ||
4174 | NT$25.35 | -2.3% | -68.5% | NT$6.7b | n/a | PS108x | n/a | n/a | ||
7829 | NT$53.60 | 0.4% | n/a | NT$4.3b | n/a | PB9.6x | n/a | n/a | ||
7827 | NT$77.90 | -0.1% | n/a | NT$9.3b | n/a | PB5551.9x | n/a | n/a |